Lucy Parsons Verona Pharma has initiated phase III trials to evaluate the safety and efficacy of nebulised ensifentrine in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). In News. Verona Pharma PLC (LON:VRP) caught the eye late on as its shares surged 89% to 81.5p. Verona Pharma news and VRNA price. Verona Pharma Daily Update: Verona Pharma Plc is listed in the … Click here to subscribe to the COPD News Today Newsletter! Verona Pharma, with a Raleigh HQ, Weighs its COPD Candidate as COVID-19 Therapy A British clinical-stage biotech firm with U.S. headquarters in Raleigh is exploring the option of repurposing its leading drug candidate to treat COVID-19 patients. In addition, Mark W. Hahn, a seasoned pharmaceutical finance executive, will join Verona Pharma as Chief Financial Officer (CFO), a non-board position, with effect from March 1, 2020. VRNA News: Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020: 10/13/2020 02:00:10 AM: VRNA News: Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Akebia announces positive data for Vadadustat in the treatment of anemia. The phosphodiesterase inhibitor ensifentrine reduces production of pro-inflammatory mediators in well-differentiated bronchial epithelial cells by inhibiting PDE4 Verona Pharma provides update for Phase 2b COPD trial. One Little-Known Tech Stock to Invest in Now The Motley Fool About Verona Pharma PLC Verona Pharma PLC. Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with … Get today's Verona Pharma ADR stock news. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Verona Pharma against related stocks people have also bought. ET by Tomi Kilgore Verona Pharma shares shoot … Verona Pharma started at buy with $17 stock price target at Canaccord Genuity Aug. 10, 2020 at 9:47 a.m. This range of Verona Pharma-supported publications provide further pharmacologic background to the research that we are engaged in. Patients Hospitalized with COVID-19 Verona Pharma has launched two Phase 3 trials to assess the safety and effectiveness of ensifentrine, its investigational inhalation treatment for chronic obstructive pulmonary disease (COPD). Verona Pharma Third Quarter 2020 Financial Results and Conference Call To participate, please dial one of the following numbers and reference conference ID … View the real-time VRNA price chart on Robinhood and decide if you want to buy or sell commission-free. Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it has entered into a debt financing facility for up to $30 million (“debt facility”) with Silicon Valley Bank (SVB). Dicerna reports … Find real-time VRNA - Verona Pharma PLC stock quotes, company profile, news and forecasts from CNN Business. View the latest Verona Pharma PLC ADR (VRNA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Free real-time prices, trades, and chat. We cover the latest Verona Pharma ADR headlines and breaking news impacting Verona Pharma ADR stock performance.